Analyst Andrew Fein from H.C. Wainwright maintained a Buy rating on Stoke Therapeutics (STOK – Research Report) and keeping the price ...

The conference brought together pioneers and enthusiasts exploring everything from life therapy and oxygen treatments to cutting ... One thing that surprised me, however, was the lack of ...

Data Safety and Monitoring Board Endorsed Dose Escalation and Broadening of Inclusion Criteria in the MyPEAKTM-1 Phase 1b/2 ...

Covering Saudi Arabia’s markets, the report includes: It encompasses a robust vendor analysis tailored to assist clients in enhancing their market positioning. Specifically, the report furnishes a ...

Repetitive transcranial magnetic stimulation offers rapid depression relief for patients unresponsive to conventional ...

Additionally, concerns about the frequency of lab monitoring or other issues related to prednisone use could impact the ...

Bodies change as they age, especially after physically demanding experiences like pregnancy. Many of those changes don't have ...

Research and development expense was $15.5 million for the third quarter of 2024, as compared to $7.6 million for the prior ...

From a seated position, straighten your posture and press the bottom of both your feet together. Placing your hands on your ...

ClearPoint Neuro reported strong YoY growth in Q3, but the stock reacted negatively. Check out my recommendation for CLPT ...

TG Therapeutics, Inc. reported a modest Q3 beat and raised the full-year net sales guidance range for Briumvi by $7.5 million ...

Discover how metabolic ketogenic therapy differs from the popular diet trend and its potential benefits for bipolar disorder.